Researcher Profile

Researcher Profile

Ali Mohamed, MD

Ali Mohamed, MD

Assistant Professor, Department of Medicine
Division of Hematology and Oncology
Disease Teams:
Gastrointestinal Cancer

Research Interests

  • Therapeutics
  • Neoplasms
  • Breast Neoplasms
  • Drug Therapy
  • Survival
  • Colonic Neoplasms
  • Estrogen Receptors
  • Triple Negative Breast Neoplasms
  • Progesterone Receptors
  • Poly(ADP-ribose) Polymerase Inhibitors
  • Aromatase Inhibitors
  • Phosphatidylinositol 3-Kinase

Clinical Trials

A Phase II Study to Evaluate the Efficacy of Nanoliposomal Irinotecan in Combination with Oxaliplatin, Leucovorin, and 5-Fuorouracil for Patients with Locally Advanced Pancreatic Carcinoma: Big Ten Cancer Research Consortium BTCRC-GI15-067
Phase 1/2 Multicenter Study of the Safety, Pharmacokinetics, and Preliminary Efficacy of APL-101 in Subjects with Non-Small Cell Lung Cancer with c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
A Phase III Multicenter, Randomized, Double-blinded, Active-controlled, Clinical Study to Evaluate the Safety and Efficacy of Lenvatinib (E7080/MK-7902) with Pembrolizumab (MK-3475) in Combination with Transarterial Chemoembolization (TACE) Versus TACE in Participants with Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012)(LEAP-012)

Recent Publications


Mirkin, KA, Hollenbeak, CS, Mohamed, A, Jia, Y, El-Deiry, WS & Messaris, E 2017, 'Impact of perineural invasion on survival in node negative colon cancer', Cancer Biology and Therapy, vol. 18, no. 9, pp. 740-745.

Clinical Trials Search

Children (age < 18 years)
Adults (age >= 18 years)